An Adverse Outcome Pathway Linking Organohalogen Exposure to Mitochondrial Disease

Adverse outcome pathways (AOPs) are pragmatic tools in human health hazard characterization and risk assessment. As such, one of the main goals of AOP development is to provide a clear, progressive, and linear mechanistic representation of pertinent toxicological key events (KEs) occurring along the...

Full description

Saved in:
Bibliographic Details
Main Authors: Brooke McMinn, Alicia L. Duval, Christie M. Sayes
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Toxicology
Online Access:http://dx.doi.org/10.1155/2019/9246495
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554670234533888
author Brooke McMinn
Alicia L. Duval
Christie M. Sayes
author_facet Brooke McMinn
Alicia L. Duval
Christie M. Sayes
author_sort Brooke McMinn
collection DOAJ
description Adverse outcome pathways (AOPs) are pragmatic tools in human health hazard characterization and risk assessment. As such, one of the main goals of AOP development is to provide a clear, progressive, and linear mechanistic representation of pertinent toxicological key events (KEs) occurring along the different levels of biological organization. Here, we present an AOP framework that depicts how exposure to organohalogens can lead to mitochondrial disease. Organohalogens are disinfectant by-products (DBPs) found in our drinking water. Chloroform, trichloroacetic acid, and trichlorophenol were selected to represent specific types of organohalogens for the development of this AOP. Although each of these compounds contains chlorine atoms, they differ in aromaticity and solubility, which have a significant impact on their potency. This AOP consists of two main pathways, both of which are triggered by the molecular initiating event (MIE) of excessive reactive oxygen species generation. Pathway 1 details the downstream consequences of oxidative stress, which include mitochondrial DNA damage, protein aggregation, and depolarization of the mitochondrial membrane. Pathway 2 shows the KEs that result from inadequate supply of glutathione, including calcium dysregulation and ATP depletion. Pathways 1 and 2 converge at a common KE: opening of the mitochondrial membrane transition pore (mPTP). This leads to the release of cytochrome c, caspase activation, apoptosis, and mitochondrial disease. This AOP was developed according to the Organisation for Economic Co-operation and Development guidance, including critical consideration of the Bradford Hill criteria for Weight of Evidence assessment and key questions for evaluating confidence. The presented AOP is expected to serve as the basis for designing new toxicological tests as well as the characterization of novel biomarkers for disinfectant by-product exposure and adverse health effects.
format Article
id doaj-art-e9f1418b4cd24b1483b1a83af8f37a6d
institution Kabale University
issn 1687-8191
1687-8205
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Journal of Toxicology
spelling doaj-art-e9f1418b4cd24b1483b1a83af8f37a6d2025-02-03T05:50:59ZengWileyJournal of Toxicology1687-81911687-82052019-01-01201910.1155/2019/92464959246495An Adverse Outcome Pathway Linking Organohalogen Exposure to Mitochondrial DiseaseBrooke McMinn0Alicia L. Duval1Christie M. Sayes2Department of Environmental Science, Baylor University, One Bear Place # 97266, Waco, TX 76798-7266, USADepartment of Environmental Science, Baylor University, One Bear Place # 97266, Waco, TX 76798-7266, USADepartment of Environmental Science, Baylor University, One Bear Place # 97266, Waco, TX 76798-7266, USAAdverse outcome pathways (AOPs) are pragmatic tools in human health hazard characterization and risk assessment. As such, one of the main goals of AOP development is to provide a clear, progressive, and linear mechanistic representation of pertinent toxicological key events (KEs) occurring along the different levels of biological organization. Here, we present an AOP framework that depicts how exposure to organohalogens can lead to mitochondrial disease. Organohalogens are disinfectant by-products (DBPs) found in our drinking water. Chloroform, trichloroacetic acid, and trichlorophenol were selected to represent specific types of organohalogens for the development of this AOP. Although each of these compounds contains chlorine atoms, they differ in aromaticity and solubility, which have a significant impact on their potency. This AOP consists of two main pathways, both of which are triggered by the molecular initiating event (MIE) of excessive reactive oxygen species generation. Pathway 1 details the downstream consequences of oxidative stress, which include mitochondrial DNA damage, protein aggregation, and depolarization of the mitochondrial membrane. Pathway 2 shows the KEs that result from inadequate supply of glutathione, including calcium dysregulation and ATP depletion. Pathways 1 and 2 converge at a common KE: opening of the mitochondrial membrane transition pore (mPTP). This leads to the release of cytochrome c, caspase activation, apoptosis, and mitochondrial disease. This AOP was developed according to the Organisation for Economic Co-operation and Development guidance, including critical consideration of the Bradford Hill criteria for Weight of Evidence assessment and key questions for evaluating confidence. The presented AOP is expected to serve as the basis for designing new toxicological tests as well as the characterization of novel biomarkers for disinfectant by-product exposure and adverse health effects.http://dx.doi.org/10.1155/2019/9246495
spellingShingle Brooke McMinn
Alicia L. Duval
Christie M. Sayes
An Adverse Outcome Pathway Linking Organohalogen Exposure to Mitochondrial Disease
Journal of Toxicology
title An Adverse Outcome Pathway Linking Organohalogen Exposure to Mitochondrial Disease
title_full An Adverse Outcome Pathway Linking Organohalogen Exposure to Mitochondrial Disease
title_fullStr An Adverse Outcome Pathway Linking Organohalogen Exposure to Mitochondrial Disease
title_full_unstemmed An Adverse Outcome Pathway Linking Organohalogen Exposure to Mitochondrial Disease
title_short An Adverse Outcome Pathway Linking Organohalogen Exposure to Mitochondrial Disease
title_sort adverse outcome pathway linking organohalogen exposure to mitochondrial disease
url http://dx.doi.org/10.1155/2019/9246495
work_keys_str_mv AT brookemcminn anadverseoutcomepathwaylinkingorganohalogenexposuretomitochondrialdisease
AT alicialduval anadverseoutcomepathwaylinkingorganohalogenexposuretomitochondrialdisease
AT christiemsayes anadverseoutcomepathwaylinkingorganohalogenexposuretomitochondrialdisease
AT brookemcminn adverseoutcomepathwaylinkingorganohalogenexposuretomitochondrialdisease
AT alicialduval adverseoutcomepathwaylinkingorganohalogenexposuretomitochondrialdisease
AT christiemsayes adverseoutcomepathwaylinkingorganohalogenexposuretomitochondrialdisease